e-learning
resources
Madrid 2019
Monday, 30.09.2019
Tuberculosis: diagnosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Efficacy of Matrix Metalloproteinase-9 in Differentiating Tuberculous from Non-Tuberculous Pleural Effusion
N. Moulaei (Zahedan, Islamic Republic of Iran), A. Niazi (Zahedan, Islamic Republic of Iran), M. Nouralahzadeh (Zahedan, Islamic Republic of Iran), M. Shahriyar (Zahedan, Islamic Republic of Iran)
Source:
International Congress 2019 – Tuberculosis: diagnosis
Session:
Tuberculosis: diagnosis
Session type:
Thematic Poster
Number:
3006
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Moulaei (Zahedan, Islamic Republic of Iran), A. Niazi (Zahedan, Islamic Republic of Iran), M. Nouralahzadeh (Zahedan, Islamic Republic of Iran), M. Shahriyar (Zahedan, Islamic Republic of Iran). Efficacy of Matrix Metalloproteinase-9 in Differentiating Tuberculous from Non-Tuberculous Pleural Effusion. 3006
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of solitary fibrous tumours of the pleura: a systematic review and meta-analysis
Utility of pleural fluid for predictive marker testing in malignant pleural effusion
Massive pleural effusion presented with a very rare multitude of complication
Related content which might interest you:
Validity of Pleural Fluid Protein in differentiating Tuberculous from Malignant Pleural Effusion
Source: International Congress 2019 – Pleural infection and complicated pneumonia
Year: 2019
Efficacy And Safety Of Thoracoscopic Cryobiopsy In Patients With Undiagnosed Exudative Pleural Effusion
Source: Virtual Congress 2020 – Interventional pulmonology: the pleura and bronchoscopic treatment of emphysema
Year: 2020
Diagnostic Utility of Closed Needle Pleural Biopsy in Exudative Pleural Effusions
Source: International Congress 2018 – Pulmonary tuberculosis: long term complications, rehabilitation and challenges
Year: 2018
Half Dose Urokinase Can Be Effective in Patients with Complicated Parapneumonic Effusion.
Source: International Congress 2017 – From microbiology to clinical work
Year: 2017
Tuberculosis Antigen Stimulated CXCR3 Ligand Assay for the Diagnosis of Tuberculous Lymphadenitis
Source: International Congress 2019 – Tuberculosis: diagnosis
Year: 2019
Management of recurrent Malignant Pleural Effusion: what is the best method?
Source: ERS Course 2015
Year: 2015
Management of recurrent Malignant Pleural Effusion: what is the best method?
Source: School Course 2014 - Thoracoscopy and Pleural Techniques
Year: 2014
Diffuse Pulmonary Non-Amyloid Light-Chain Deposition Disease: Phenotypes and Outcome
Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases
Year: 2021
Bedside Ultrasound and Pigtail Catheters for Management of Pleural Effusion in Geriatric Population
Source: International Congress 2018 – Pleural diseases and pneumonia: what's new ?
Year: 2018
Modes of Disease Progression in Different Forms of Interstitial Lung Disease with Usual Interstitial Pneumonia Histology in Patients with Idiopathic and Non-idiopathic Etiologies - A Single Center Experience
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019
Diagnosing Pulmonary Tuberculosis by Pooling Induced Sputum
Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections
Year: 2017
Development Of A Machine Learning Combination With Deep Learning For Diagnosing Idiopathic Pulmonary Fibrosis In Chronic Interstitial Lung Disease
Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020
Community-Acquired Pneumonia with Evolving Cavitation and Peripheral Eosinophilia
Source: International Congress 2018 – CC8 Non-resolving pneumonia
Year: 2018
Mini-thoracoscopy vs Semirigid Thoracoscopy in Undiagnosed Exudative Pleural Effusions: A Randomized Controlled Trial
Source: International Congress 2018 – Interventional pulmonology highlights in 2018: latest innovations
Year: 2018
Late Breaking Abstract - BBT-877, a Potent Autotaxin Inhibitor in Clinical Development to Treat Idiopathic Pulmonary Fibrosis
Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia
Year: 2019
Imaging in Pleural Infections: The Radiation Adds Up
Source: International Congress 2017 – Pleural and mediastinal malignancies
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept